Header Logo

Connection

MADHAVA BEERAM to Neoplasms

Back to Details
This is a "connection" page, showing publications MADHAVA BEERAM has written about Neoplasms.
MADHAVA BEERAM
Connection Strength
0.045
Neoplasms
  1. First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas. Ann Oncol. 2016 10; 27(10):1928-40.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.